A detailed history of West Michigan Advisors, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, West Michigan Advisors, LLC holds 31,000 shares of ARDX stock, worth $163,990. This represents 0.08% of its overall portfolio holdings.

Number of Shares
31,000
Previous 41,250 24.85%
Holding current value
$163,990
Previous $255,000 11.37%
% of portfolio
0.08%
Previous 0.1%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$6.05 - $9.74 $62,012 - $99,835
-10,250 Reduced 24.85%
31,000 $226,000
Q4 2023

Feb 13, 2024

BUY
$3.29 - $6.64 $135,712 - $273,900
41,250 New
41,250 $255,000
Q1 2023

Apr 21, 2023

BUY
$2.68 - $4.79 $67,000 - $119,750
25,000 New
25,000 $119,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $818M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track West Michigan Advisors, LLC Portfolio

Follow West Michigan Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Michigan Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on West Michigan Advisors, LLC with notifications on news.